Fund name: Sofinnova Crossover Fund 1
Amount raised: $540 million
Stage of fundraising: Final close
Final close date: March 2021
Legal advisor: Clifford Chance
Placement agent: Triago
Sofinnova Partners has raised a $540 million for Sofinnova Crossover Fund 1, according to a recent press release by the firm. The fund will provide growth capital to European companies in the life science and healthcare sector.
The Sofinnova Crossover Fund was oversubscribed and attracted commitments from institutional investors such as BPI France and CNP Assurances. The firm used Triago as a placement agent for the crossover fund and the US based law firm Clifford Chance acted as legal counsel.